D'AGOSTINO, Mattia
D'AGOSTINO, Mattia
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
2021-01-01 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
2020-01-01 D'Agostino M.; Raje N.
Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen?
2020-01-01 D'Agostino M.; Mina R.; Gay F.
Anticorpi monoclonali bispecifici nel trattamento del mieloma multiplo
2019-01-01 Mattia D'Agostino; Mario Boccadoro
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial
2021-01-01 Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario
CD38 as an immunotherapeutic target in multiple myeloma
2018-01-01 Bonello F.; D'Agostino M.; Moscvin M.; Cerrato C.; Boccadoro M.; Gay F.
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino
2019-01-01 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma
2019-01-01 D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F.
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
2020-01-01 Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A.
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials
2018-01-01 D'Agostino M.; De Paoli L.; Conticello C.; Offidani M.; Ria R.; Petrucci M.T.; Spada S.; Marcatti M.; Catalano L.; Gilestro M.; Guglielmelli T.; Baldini L.; Gamberi B.; Rizzi R.; De Sabbata G.; Di Renzo N.; Patriarca F.; Pezzatti S.; Siniscalchi A.; Ribolla R.; Palumbo A.; Montefusco V.; Nagler A.; Boccadoro M.; Gay F.
Determining treatment intensity in elderly patients with multiple myeloma
2018-01-01 Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S.
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma
2021-01-01 Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
2020-01-01 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?
2023-01-01 D'Agostino, Mattia; Terragna, Carolina; van Duin, Mark
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
2021-01-01 Bruno, Benedetto; Wäsch, Ralph; Engelhardt, Monika; Gay, Francesca; Giaccone, Luisa; D'Agostino, Mattia; Rodríguez-Lobato, Luis-Gerardo; Danhof, Sophia; Gagelmann, Nico; Kröger, Nicolaus; Popat, Rakesh; Van de Donk, Niels W C J; Terpos, Evangelos; Dimopoulos, Meletios A; Sonneveld, Pieter; Einsele, Hermann; Boccadoro, Mario
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma
2021-01-01 Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò
Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients
2018-01-01 Larocca, Alessandra*; D'Agostino, Mattia; Boccadoro, Mario
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status
2022-01-01 Giannotta, Claudia; Castella, Barbara; Tripoli, Ezio; Grimaldi, Daniele; Avonto, Ilaria; D’Agostino, Mattia; Larocca, Alessandra; Kopecka, Joanna; Grasso, Mariella; Riganti, Chiara; Massaia, Massimo
Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop
2023-01-01 Terpos E.; Neri P.; van de Donk N.W.C.J.; D'Agostino M.; Parekh S.; Jagannath S.; Ludwig H.; Avigan D.E.; Dhodapkar M.V.; Raje N.S.
IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA
2022-01-01 C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma | 2021 | Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P. | |
| Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better? | 2020 | D'Agostino M.; Raje N. | |
| Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen? | 2020 | D'Agostino M.; Mina R.; Gay F. | |
| Anticorpi monoclonali bispecifici nel trattamento del mieloma multiplo | 2019 | Mattia D'Agostino; Mario Boccadoro | |
| Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial | 2021 | Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario | |
| CD38 as an immunotherapeutic target in multiple myeloma | 2018 | Bonello F.; D'Agostino M.; Moscvin M.; Cerrato C.; Boccadoro M.; Gay F. | |
| Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro | |
| Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma | 2019 | D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F. | |
| Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma | 2020 | Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A. | |
| Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials | 2018 | D'Agostino M.; De Paoli L.; Conticello C.; Offidani M.; Ria R.; Petrucci M.T.; Spada S.; Marcatti M.; Catalano L.; Gilestro M.; Guglielmelli T.; Baldini L.; Gamberi B.; Rizzi R.; De Sabbata G.; Di Renzo N.; Patriarca F.; Pezzatti S.; Siniscalchi A.; Ribolla R.; Palumbo A.; Montefusco V.; Nagler A.; Boccadoro M.; Gay F. | |
| Determining treatment intensity in elderly patients with multiple myeloma | 2018 | Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S. | |
| Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma | 2021 | Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara | |
| Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing | 2020 | D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca | |
| Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment? | 2023 | D'Agostino, Mattia; Terragna, Carolina; van Duin, Mark | |
| European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma | 2021 | Bruno, Benedetto; Wäsch, Ralph; Engelhardt, Monika; Gay, Francesca; Giaccone, Luisa; D'Agostino, Mattia; Rodríguez-Lobato, Luis-Gerardo; Danhof, Sophia; Gagelmann, Nico; Kröger, Nicolaus; Popat, Rakesh; Van de Donk, Niels W C J; Terpos, Evangelos; Dimopoulos, Meletios A; Sonneveld, Pieter; Einsele, Hermann; Boccadoro, Mario | |
| Functional impact of genomic complexity on the transcriptome of Multiple Myeloma | 2021 | Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò | |
| Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients | 2018 | Larocca, Alessandra*; D'Agostino, Mattia; Boccadoro, Mario | |
| Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status | 2022 | Giannotta, Claudia; Castella, Barbara; Tripoli, Ezio; Grimaldi, Daniele; Avonto, Ilaria; D’Agostino, Mattia; Larocca, Alessandra; Kopecka, Joanna; Grasso, Mariella; Riganti, Chiara; Massaia, Massimo | |
| Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop | 2023 | Terpos E.; Neri P.; van de Donk N.W.C.J.; D'Agostino M.; Parekh S.; Jagannath S.; Ludwig H.; Avigan D.E.; Dhodapkar M.V.; Raje N.S. | |
| IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA | 2022 | C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia. |